Tianjin Pharma DRT (SH600329)

中文
中文English
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
Join Us
Talent Concept
Recruitment Information
Contact Us
Contact Us

Tianjin Pharma DRT (SH600329)

35.17 +0.35 +1.01%

中文English
Home Page
Group Profile
Group IntroductionHistoryCorporate CultureGroup IndustryESGBrand Display
Heritage of Ingenuity
Product Center
Product FamilyProducts and Services
Group News
Health Guide
Health InformationMedia Coverage
Investor Relations
Stock InformationCompany AnnouncementsInvestor Contact
Join Us
Talent ConceptRecruitment Information
Contact Us

Online Mall
Back
Home Page Group News Content
To S-Shareholders: NOTICE OF ANNUAL GENERAL MEETING FOR FY2025
2026 / 04 / 30







Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited - Proxy Form of AGM

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED ANNUAL REPORT 2025

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited - Annexure dated 30 April 2026


Previous：致敬！章臣桂教授荣获全国五一劳动奖章，第六中药厂摘得全国五一劳动奖状 Next：致A股股东：关于召开公司2025年年度股东大会的通知
We are the Leader of Chinese Medicine and Striving to Become a Leader in Innovative Medicine in China
Group Profile
Heritage of Ingenuity
Product Center
Group News
Health Guide
Investor Relations
Join Us
Contact Us
Address: 78 Shenton Way, #19-02
Singapore：079120
Tel：+65 6514 0579
Fax：+65 6514 0439
JICPB No. 2022007352 JGWAB No.12010402000399
Internet Drug Information Service Qualification Certificate No.: (Tianjin) - Non operational -2020-0021
© 2023 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Powered by xinhongru.
Privacy Policy Legal Statement